ATA Guidelines Tools

Thyroid Disease in Preconception, Pregnancy, and Postpartum

American Thyroid Association Quick-Reference GUIDELINES Apps

Issue link: https://eguideline.guidelinecentral.com/i/1545288

Contents of this Issue

Navigation

Page 23 of 53

Hypothyroidism 24 Recommendations Table 12. Isolated Hypothyroxinemia Preconception and in Pregnancy Strength * Level # For maternal isolated hypothyroxinemia diagnosed in the first trimester, do not offer levothyroxine treatment. Conditional Low For maternal isolated hypothyroxinemia diagnosed aer the first trimester, levothyroxine treatment should not be offered. Strong High * Strength of Recommendation; # Level of Evidence; Good Practice Statement. Box 4. Perinatal TgAb Positivity and Other Signs of Thyroid Autoimmunity TgAb positivity is a reflection of thyroid autoimmunity and a risk factor for overt hypothyroidism during pregnancy. However, TgAb positivity has less diagnostic accuracy for hypothyroidism than TPOAb positivity. Furthermore, as compared to (euthyroid) TPOAb positivity, it is less likely that (euthyroid) TgAb positivity is a risk factor for miscarriage or preterm birth. For these reasons, there are more studies available on TPOAb positivity, and TPOAb positivity remains the primary thyroid antibody to be checked for etiological or prognostic purposes both in pregnant and non-pregnant individuals. Some studies in non-pregnant individuals have suggested that thyroid sonography can identify individuals with thyroid antibody negative thyroid autoimmunity. However, the lack of data in the perinatal period limits the usefulness of ultrasound for detecting thyroid autoimmunity. Moreover, if the indication for a thyroid ultrasound is unclear, the risks of diagnosing thyroid nodules or small (i.e., not clinically meaningful) thyroid cancers, which might result in additional testing or treatment, is more likely to outweigh any benefits. • There is no indication for routine perinatal TgAb measurements. • If a woman is known to have isolated TgAb positivity or previous incidental signs of thyroid autoimmunity on ultrasound when entering the perinatal period, it is sensible to approach thyroid management similar to the recommendations for TPOAb positive women. • A small subgroup in which additional TgAb measurement could be considered for the purpose of identifying an indication for preconception or gestational thyroid function screening would be a euthyroid TPOAb negative woman with a high risk of thyroid autoimmunity (for example: previous thyroiditis, concomitant autoimmune disease, first degree relative with thyroid autoimmunity) and a high-normal TSH.

Articles in this issue

Archives of this issue

view archives of ATA Guidelines Tools - Thyroid Disease in Preconception, Pregnancy, and Postpartum